Lexaria Bioscience Corp.
LEXX Nasdaq
SEC CIK 1348362
Follow Lexaria Bioscience Corp.
Weekly email: filings, results
Revenue, last quarter
$0
−100% vs same quarter last year
Net income
−$2M
+47.4% vs same quarter last year
EPS, diluted
−$0.08
+61.9% vs same quarter last year
Operating cash flow
−$1.6M
+54.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $705.9K | −$11.9M |
| FY24 | $464.3K | −$5.8M |
| FY23 | $226.2K | −$6.7M |
| FY22 | $255.4K | −$7.3M |
| FY21 | $722.7K | −$4M |
| FY20 | $384.5K | −$4.1M |
| FY19 | $222.6K | - |
| FY18 | $433.3K | - |
| FY17 | $63.6K | −$1.9M |
| FY16 | $40.7K | −$1.3M |
| FY15 | $14.7K | −$2M |
| FY14 | $0 | −$1.6M |
| FY13 | - | - |
| FY12 | - | −$538.2K |
| FY11 | - | −$552.5K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 99.6% | −1683% | −1686% |
| FY24 | 99% | −1239.2% | −1248.2% |
| FY23 | 86.1% | −2888.5% | −2946.4% |
| FY22 | 71.9% | −2591.7% | −2846.3% |
| FY21 | 75.7% | −786.8% | −557.2% |
| FY20 | 56% | - | −1062.2% |
| FY19 | 89.7% | - | - |
| FY18 | 94.2% | - | - |
| FY17 | 53.3% | - | −3031.9% |
| FY16 | −12% | −3136.8% | −3136.8% |
| FY15 | −103.3% | −13489.8% | −13489.8% |
| FY14 | - | - | - |
| FY13 | - | - | - |
| FY12 | - | - | - |
| FY11 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$10.5M |
| FY24 | −$5M |
| FY23 | −$5.9M |
| FY22 | −$4.9M |
| FY21 | - |
| FY20 | −$2.6M |
| FY19 | −$3.7M |
| FY18 | - |
| FY17 | −$1.5M |
| FY16 | −$664K |
| FY15 | −$1.5M |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- Lexaria Bioscience Corp.
- Healthcare median
Show the numbers
| Year | Lexaria Bioscience Corp. | Healthcare median |
|---|---|---|
| FY25 | −1686% | −30.6% |
| FY24 | −1248.2% | −47% |
| FY23 | −2946.4% | −58% |
| FY22 | −2846.3% | −80.4% |
| FY21 | −557.2% | −71.9% |
| FY20 | −1062.2% | −62.2% |
| FY19 | - | −46.3% |
| FY18 | - | −49.6% |
| FY17 | −3031.9% | −45.9% |
| FY16 | −3136.8% | −36% |
| FY15 | −13489.8% | −38.4% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |
| FY11 | - | −27.9% |